Answers are grounded in this paper and cite their sources.
Risk and rates for atherosclerotic complications and HF are generally decreasing among individuals with T2D, although HF incidence has notably plateaued in recent years. Modifiable risk factors within target levels were associated with lower risks for outcomes. This was particularly notable for systolic blood pressure and glycated hemoglobin for atherosclerotic outcomes and body mass index for heart failure.
No takes yet. Share an insight, caveat, or question.
Sattar et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: